Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis

Journal of Allergy and Clinical Immunology

Volumn 133, Issue 1, 2014, Pages

  Bochenek, Grazyna ^a   Kuschill Dziurda, Joanna ^a   Szafraniec, Krystyna ^a   Plutecka, Hanna ^a   Szczeklik, Andrzej ^a   Nizankowska Mogilnicka, Ewa ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Aspirin; aspirin exacerbated respiratory disease; asthma phenotype; latent class analysis; nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; LEUKOTRIENE E4;

ADULT; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; ATOPY; BRONCHUS OBSTRUCTION; CHRONIC RHINOSINUSITIS; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SPIROMETRY; UPPER RESPIRATORY TRACT;

AERD; ASPIRIN; ASPIRIN-EXACERBATED RESPIRATORY DISEASE; ASTHMA PHENOTYPE; CYSLT; CYSTEINYL LEUKOTRIENE; ED; EMERGENCY DEPARTMENT; ICU; INTENSIVE CARE UNIT; LATENT CLASS ANALYSIS; LCA; LEUKOTRIENE E(4); LTE(4); NAEPP EPR3; NATIONAL ASTHMA EDUCATION AND PREVENTION PROGRAM EXPERT PANEL REPORT 3; NONSTEROIDAL ANTI-INFLAMMATORY DRUG; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS; NSAID; TENOR; THE EPIDEMIOLOGY AND NATURAL HISTORY OF ASTHMA: OUTCOMES AND TREATMENT REGIMENS;

ADULT; AIRWAY OBSTRUCTION; ASTHMA, ASPIRIN-INDUCED; CELL MOVEMENT; EOSINOPHILS; FEMALE; HUMANS; LEUKOTRIENE E4; MALE; MIDDLE AGED; NASAL POLYPS; SINUSITIS; SPIROMETRY; STATISTICS AS TOPIC;

EID: 84891738600     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.07.004     Document Type: Article

References (39)

1. M. Samter, and R. Beers Jr. Intolerance to aspirin: clinical studies and consideration of its pathogenesis Ann Intern Med 68 1968 975 983
2. A. Szczeklik, E. Nizankowska, and M. Duplaga Natural history of aspirin-induced asthma Eur Respir J 16 2000 432 436
3. D.D. Stevenson, and A. Szczeklik Clinical and pathologic perspectives on aspirin sensitivity and asthma J Allergy Clin Immunol 118 2006 773 786
4. M.P. Berges-Gimeno, R.A. Simon, and D.D. Stevenson The natural history and clinical characteristics of aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 89 2002 474 478
5. G. Bochenek, E. Nizankowska, and A. Szczeklik Atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs Allergy 51 1996 16 23
6. 4 excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA Allergy 65 2010 662 669
7. S.E. Wenzel Asthma: defining of the persistent adult phenotypes Lancet 368 2006 804 813
8. K. Mascia, T. Haselkorn, Y.M. Deniz, D.P. Miller, E.R. Bleecker, and L. Borish et al. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to treat asthma J Allergy Clin Immunol 116 2005 970 975
9. J. Henderson, R. Granell, J. Heron, A. Sheriff, A. Simpson, and A. Woodcock et al. Association of wheezing phenotypes In the first six years of life with atopy, lung function and airway responsiveness Thorax 63 2008 974 980
10. B.D. Spycher, M. Silverman, A.M. Brooke, C.E. Minder, and C.E. Kuehni Distinguishing phenotypes of childhood wheeze and cough using latent class analysis Eur Respir J 31 2008 974 981
11. V. Siroux, X. Basagna, A. Boudier, I. Pin, J. Garcia-Aymerich, and A. Vesin et al. Identifying adult asthma phenotypes using a clustering approach Eur Respir J 38 2011 310 317
12. P. Haldar, I.D. Pavord, E.S. Dominic, M.A. Berry, M. Thomas, and C.E. Brightling et al. Cluster analysis and clinical asthma phenotypes Am J Respir Crit Care Med 178 2008 218 224
13. W.C. Moore, D.A. Meyers, S.E. Wenzel, W.G. Teague, H. Li, and X. Li et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program Am J Respir Crit Care Med 181 2009 315 323
14. A.M. Fitzpatrick, W.G. Teague, D.A. Meyers, S.P. Peters, X. Li, and H. Li et al. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program Am J Respir Crit Care Med 127 2011 382 389
15. E. Nizankowska-Mogilnicka, G. Bochenek, L. Mastalerz, M. Swierczyńska, C. Picado, and G. Scadding et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity Allergy 62 2007 1111 1118
16. National Heart, Lung, and Blood Institute, and National Asthma Education and Prevention Program Expert panel report 3: guidelines for the diagnosis and management of asthma 2007 National Heart, Lung, and Blood Institute Bethesda
17. J.A. Hagenars, and A.L. McCutheon Applied latent class analysis 2002 Cambridge University Press Cambridge (United Kingdom)
18. S.T. Lanza, L.M. Collins, D.R. Lemmon, and J.L. Schafer PROC LCA: SAS procedure for latent class analysis Struct Equ Modelling 14 2007 671 694
19. S.K. Chhabra, and P. Chhabra Gender differences in perception of dyspnoea, assessment of control, and quality of life in asthma J Asthma 48 2011 609 615
20. B.H. Rowe, D.C. Voaklander, D. Wang, A. Senthilselvan, T.P. Klassen, and T.J. Marrie et al. Asthma presentation by adults to emergency departments in Alberta, Canada: a large population-based study Chest 135 2009 57 65
21. The ENFUMOSA Study Group The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Eur Respir J 22 2003 470 477
22. M.L. Kowalski, M. Cieslak, C.A. Perez-Novo, J.S. Makowska, and C. Bachert Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies Allergy 66 2011 32 38
23. F. Yoshimine, T. Hasegawa, E. Suzuki, M. Terada, T. Koya, and A. Kondoh et al. Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan Respirology 10 2005 477 484
24. Y. Fukutomi, M. Taniguschi, T. Tsuburai, H. Tanimoto, C. Oshikata, and E. Ono et al. Obesity and aspirin intolerance are risk factors for difficult-to treat asthma in Japanese non-atopic women Clin Exp Allergy 45 2012 738 746
25. M. Wearthall, J. Travers, P.M. Shirtcliffe, S.E. Marsh, M.V. Williams, and M.R. Novitz et al. Distinct clinical phenotypes of airways disease defined by cluster analysis Eur Respir J 34 2009 812 818
26. M. Mikos, P. Grzanka, K. Sladek, G. Pulka, G. Bochenek, and J. Soja et al. High-resolution computed tomography evaluation of peripheral airways in asthma patients: comparison of focal and diffuse air-trapping Respiration 77 2009 381 388
27. K. Mascia, L. Borish, J. Patrie, J. Hunt, C.D. Phillips, and J.W. Steinke Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease Ann Allergy Asthma Immunol 94 2005 652 657
28. E.V. Ponte, R. Franco, H.F. Nascimento, A. Souza-Machado, S. Cunha, and M.L. Baretto et al. Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis Allergy 63 2008 564 569
29. P.A. Williamson, S. Vaidyanathan, K. Clearie, M. Barnes, and B.J. Lipworth Airway dysfunction in nasal polyposis: a spectrum of asthmatic disease? Clin Exp Allergy 41 2011 1379 1385
30. W.J. Fokkens, V.J. Lund, J. Mullol, C. Bachert, I. Alobid, and F. Baroody et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists Rhinology 50 2012 1 12
31. Y. Hu, P.P. Cao, G.T. Liang, Y.H. Cui, and Z. Liu Diagnostic significance of blood eosinophil count in eosinophilic rhinosinusitis with nasal polyps in Chinese adults Laryngoscope 122 2012 498 503
32. 2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge J Allergy Clin Immunol 111 2003 743 749
33. 4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis J Allergy Clin Immunol 113 2004 277 283
34. S. Szefler, S. Wenzel, R. Brown, S.C. Erzurum, J.V. Fahy, and R.G. Hamilton et al. Asthma outcomes: Biomarkers J Allergy Clin Immunol 129 suppl 2012 S9 S23
35. National Heart, Lung, and Blood Institute, and National Asthma Education and Prevention Program Expert panel report 3: guidelines for the diagnosis and management of asthma 2007 National Heart, Lung, and Blood Institute Bethesda
36. R.A. Nathan, C.A. Sorkness, M. Kosinski, M. Schatz, J.T. Li, and P. Marcus et al. Development of the asthma control test: a survey for assessing asthma control J Allergy Clin Immunol 113 2004 59 65
37. M. Kumlin Measurement of leukotrienes in humans Am J Respir Crit Care Med 161 2000 102 106
38. J.A. Hagenars, and A.L. McCutheon Applied latent class analysis 2002 Cambridge University Press Cambridge (United Kingdom)
39. S.T. Lanza, L.M. Collins, D.R. Lemmon, and J.L. Schafer PROC LCA: SAS procedure for latent class analysis Struct Equ Modelling 14 2007 671 694